Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study
Introduction: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited. This study aimed to identify risk factors for COVID-19-associated mucormycosis. Methods: A case-control stu...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1984_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849236087648550912 |
|---|---|
| author | Akkilagunta Sujiv N. R. Aiswarya Lakshmi Pradeep Ramrao Deshmukh Jaya Prasad Tripathy Mubashshera F. Khan Victoria Thomas |
| author_facet | Akkilagunta Sujiv N. R. Aiswarya Lakshmi Pradeep Ramrao Deshmukh Jaya Prasad Tripathy Mubashshera F. Khan Victoria Thomas |
| author_sort | Akkilagunta Sujiv |
| collection | DOAJ |
| description | Introduction:
Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited. This study aimed to identify risk factors for COVID-19-associated mucormycosis.
Methods:
A case-control study was conducted in the Nagpur district. Cases were recruited from suspected or confirmed mucormycosis cases reported to district health authorities. Controls were household members who had COVID-19 but did not develop mucormycosis. Predisposing and treatment-related factors were analyzed.
Results:
Analysis revealed significant associations between mucormycosis and diabetes mellitus (OR-10.8; CI-1.1–103.6) and corticosteroid use (OR-97.6; CI-3.2–2927.1). Factors such as humidifier use and mask usage did not show a significant association.
Conclusion:
Optimal use of oxygen and corticosteroids is crucial, particularly in diabetic COVID-19 patients, to prevent mucormycosis. |
| format | Article |
| id | doaj-art-73c84d9f84db4cd382ed2348e3eefbce |
| institution | Kabale University |
| issn | 2249-4863 2278-7135 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Family Medicine and Primary Care |
| spelling | doaj-art-73c84d9f84db4cd382ed2348e3eefbce2025-08-20T04:02:28ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352025-07-011472805280910.4103/jfmpc.jfmpc_1984_24Risk factors for COVID-19-associated mucormycosis (CAM): A case-control studyAkkilagunta SujivN. R. Aiswarya LakshmiPradeep Ramrao DeshmukhJaya Prasad TripathyMubashshera F. KhanVictoria ThomasIntroduction: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited. This study aimed to identify risk factors for COVID-19-associated mucormycosis. Methods: A case-control study was conducted in the Nagpur district. Cases were recruited from suspected or confirmed mucormycosis cases reported to district health authorities. Controls were household members who had COVID-19 but did not develop mucormycosis. Predisposing and treatment-related factors were analyzed. Results: Analysis revealed significant associations between mucormycosis and diabetes mellitus (OR-10.8; CI-1.1–103.6) and corticosteroid use (OR-97.6; CI-3.2–2927.1). Factors such as humidifier use and mask usage did not show a significant association. Conclusion: Optimal use of oxygen and corticosteroids is crucial, particularly in diabetic COVID-19 patients, to prevent mucormycosis.https://journals.lww.com/10.4103/jfmpc.jfmpc_1984_24case-control studycovid-19mucormycosisrisk factor |
| spellingShingle | Akkilagunta Sujiv N. R. Aiswarya Lakshmi Pradeep Ramrao Deshmukh Jaya Prasad Tripathy Mubashshera F. Khan Victoria Thomas Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study Journal of Family Medicine and Primary Care case-control study covid-19 mucormycosis risk factor |
| title | Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study |
| title_full | Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study |
| title_fullStr | Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study |
| title_full_unstemmed | Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study |
| title_short | Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study |
| title_sort | risk factors for covid 19 associated mucormycosis cam a case control study |
| topic | case-control study covid-19 mucormycosis risk factor |
| url | https://journals.lww.com/10.4103/jfmpc.jfmpc_1984_24 |
| work_keys_str_mv | AT akkilaguntasujiv riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy AT nraiswaryalakshmi riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy AT pradeepramraodeshmukh riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy AT jayaprasadtripathy riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy AT mubashsherafkhan riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy AT victoriathomas riskfactorsforcovid19associatedmucormycosiscamacasecontrolstudy |